By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Vaxart, Inc. 

600 Townsend Street
Suite 120E
San Francisco  California  94103  U.S.A.
Phone: 415-437-0132 Fax:




Company News
Vaxart, Inc. To Present At The 14th Annual Needham Healthcare Conference In New York City On Tuesday, April 14, 2015 4/7/2015 10:51:19 AM
Vaxart, Inc. Completes Financing To Fund Expanding Development Portfolio 1/8/2015 10:56:58 AM
Vaxart, Inc. To Present At The 7th Annual Biotech Showcase™ In San Francisco On Wednesday, January 14, 2015 1/8/2015 10:42:44 AM
Vaxart, Inc. Accelerates Development Of Ebola Tablet Vaccine 10/23/2014 10:05:12 AM
Vaxart, Inc.’s Tablet Vaccine For H1N1 Influenza Generates Protective Immunity Equivalent To Injectable In Phase I Clinical Study 10/14/2014 8:09:47 AM
Vaxart, Inc. To Present At The JMP Securities Life Sciences Private Company Conference On Friday, October 17, 2014 10/9/2014 10:42:39 AM
Vaxart, Inc. To Present At The 15th Annual World Vaccine Congress In Brussels 10/8/2014 7:57:50 AM
Vaxart, Inc. Appoints John Harland As Chief Financial Officer 5/8/2014 9:36:00 AM
Vaxart, Inc.’s Oral H1N1 Influenza Vaccine Generates Protective Immunity 1/9/2014 10:20:57 AM
Flu Vaccine Developer Vaxart, Inc. Snags $20 Million 8/7/2013 7:55:33 AM